17 February 2021
The UK Government has announced funding to a Phase I clinical trial platform to fast-track research and development of the most innovative Covid-19 treatments. The move will allow the best researchers to study treatments in the UK and will also offer cutting-edge treatments to NHS patients in months rather than years.
Medical research charity LifeArc announced that it will be providing in $6.94m funding to assist the GenOMICC Covid-19 study carried out by the GenOMICC consortium and Genomics England. Launched in May 2020, the study uses genomics to understand why some people are severely affected by Covid-19.